{"transactions":[{"id":955315,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-01-03T02:00:17.000Z","date":"2026-01-02","kind":"sale","planned":false,"acquired":false,"shares":1879,"price":13.73,"value":25798.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units."}],"balance_after":83095,"source":{"system":"sec-edgar","filing":"0001864159-26-000002","document":"form4-01022026_090112.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000186415926000002/form4-01022026_090112.xml","form_type":"4"}},{"id":981745,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-12-04T01:00:11.000Z","date":"2025-12-01","kind":"exercise","planned":true,"acquired":false,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately exercisable."}],"balance_after":114768,"derivative":{"exercise_price":10.59,"expiration_date":"2031-05-13","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001864159-25-000006","document":"form4-12032025_081207.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000186415925000006/form4-12032025_081207.xml","form_type":"4"}},{"id":981744,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-12-04T01:00:11.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":633,"price":33.5247,"value":21221.1351,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $33.5247 and the range of prices were between $33.28 and $33.92. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":84974,"source":{"system":"sec-edgar","filing":"0001864159-25-000006","document":"form4-12032025_081207.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000186415925000006/form4-12032025_081207.xml","form_type":"4"}},{"id":981743,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-12-04T01:00:11.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":2700,"price":32.8548,"value":88707.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $32.8548 and the range of prices were between $32.27 and $33.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":85607,"source":{"system":"sec-edgar","filing":"0001864159-25-000006","document":"form4-12032025_081207.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000186415925000006/form4-12032025_081207.xml","form_type":"4"}},{"id":981742,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-12-04T01:00:11.000Z","date":"2025-12-01","kind":"exercise","planned":true,"acquired":true,"shares":3333,"price":10.59,"value":35296.47,"ownership":{"direct":true},"balance_after":88307,"source":{"system":"sec-edgar","filing":"0001864159-25-000006","document":"form4-12032025_081207.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000186415925000006/form4-12032025_081207.xml","form_type":"4"}},{"id":998981,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-11-15T01:00:16.000Z","date":"2025-11-14","kind":"exercise","planned":true,"acquired":false,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":118101,"derivative":{"exercise_price":10.59,"expiration_date":"2031-05-13","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001864159-25-000005","document":"form4-11142025_081103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000186415925000005/form4-11142025_081103.xml","form_type":"4"}},{"id":998980,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-11-15T01:00:16.000Z","date":"2025-11-14","kind":"sale","planned":true,"acquired":false,"shares":3333,"price":30,"value":99990.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024."}],"balance_after":84974,"source":{"system":"sec-edgar","filing":"0001864159-25-000005","document":"form4-11142025_081103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000186415925000005/form4-11142025_081103.xml","form_type":"4"}},{"id":998979,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-11-15T01:00:16.000Z","date":"2025-11-14","kind":"exercise","planned":true,"acquired":true,"shares":3333,"price":10.59,"value":35296.47,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1 share acquired under the Issuer's 2021 Employee Stock Purchase Plan (the \"Plan\") on November 15, 2024 and 2,834 shares acquired under the Plan on May 15, 2025."}],"balance_after":88307,"source":{"system":"sec-edgar","filing":"0001864159-25-000005","document":"form4-11142025_081103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000186415925000005/form4-11142025_081103.xml","form_type":"4"}},{"id":1011431,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-10-31T00:00:05.000Z","date":"2025-10-28","kind":"exercise","planned":true,"acquired":false,"shares":6666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":121434,"derivative":{"exercise_price":10.59,"expiration_date":"2031-05-13","underlying":"Common Stock","underlying_shares":6666},"source":{"system":"sec-edgar","filing":"0001864159-25-000003","document":"form4-10302025_081001.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000186415925000003/form4-10302025_081001.xml","form_type":"4"}},{"id":1011430,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-10-31T00:00:05.000Z","date":"2025-10-28","kind":"exercise","planned":true,"acquired":false,"shares":9999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":77333,"derivative":{"exercise_price":4.21,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":9999},"source":{"system":"sec-edgar","filing":"0001864159-25-000003","document":"form4-10302025_081001.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000186415925000003/form4-10302025_081001.xml","form_type":"4"}},{"id":1011429,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-10-31T00:00:05.000Z","date":"2025-10-28","kind":"sale","planned":true,"acquired":false,"shares":16665,"price":30.0622,"value":500986.563,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $30.0622 and the range of prices were between $30.00 and $30.49. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":82139,"source":{"system":"sec-edgar","filing":"0001864159-25-000003","document":"form4-10302025_081001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000186415925000003/form4-10302025_081001.xml","form_type":"4"}},{"id":1011428,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-10-31T00:00:05.000Z","date":"2025-10-28","kind":"exercise","planned":true,"acquired":true,"shares":6666,"price":10.59,"value":70592.94,"ownership":{"direct":true},"balance_after":98804,"source":{"system":"sec-edgar","filing":"0001864159-25-000003","document":"form4-10302025_081001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000186415925000003/form4-10302025_081001.xml","form_type":"4"}},{"id":1011427,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-10-31T00:00:05.000Z","date":"2025-10-28","kind":"exercise","planned":true,"acquired":true,"shares":9999,"price":4.21,"value":42095.79,"ownership":{"direct":true},"balance_after":92138,"source":{"system":"sec-edgar","filing":"0001864159-25-000003","document":"form4-10302025_081001.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000186415925000003/form4-10302025_081001.xml","form_type":"4"}},{"id":1161294,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-05-03T00:00:06.000Z","date":"2025-05-01","kind":"exercise","planned":true,"acquired":false,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately exercisable."}],"balance_after":87332,"derivative":{"exercise_price":4.21,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001415889-25-011874","document":"form4-05022025_080503.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588925011874/form4-05022025_080503.xml","form_type":"4"}},{"id":1161293,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-05-03T00:00:06.000Z","date":"2025-05-01","kind":"sale","planned":true,"acquired":false,"shares":400,"price":32.6034,"value":13041.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $32.6034 and the range of prices were between $32.52 and $33.66. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":82139,"source":{"system":"sec-edgar","filing":"0001415889-25-011874","document":"form4-05022025_080503.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588925011874/form4-05022025_080503.xml","form_type":"4"}},{"id":1161292,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-05-03T00:00:06.000Z","date":"2025-05-01","kind":"sale","planned":true,"acquired":false,"shares":2933,"price":31.9479,"value":93703.1907,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $31.9479 and the range of prices were between $31.44 and $32.38. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":82539,"source":{"system":"sec-edgar","filing":"0001415889-25-011874","document":"form4-05022025_080503.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588925011874/form4-05022025_080503.xml","form_type":"4"}},{"id":1161291,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-05-03T00:00:06.000Z","date":"2025-05-01","kind":"exercise","planned":true,"acquired":true,"shares":3333,"price":4.21,"value":14031.93,"ownership":{"direct":true},"balance_after":85472,"source":{"system":"sec-edgar","filing":"0001415889-25-011874","document":"form4-05022025_080503.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588925011874/form4-05022025_080503.xml","form_type":"4"}},{"id":1167134,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-24T00:00:05.000Z","date":"2025-04-21","kind":"exercise","planned":true,"acquired":false,"shares":3334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Immediately exercisable."}],"balance_after":90665,"derivative":{"exercise_price":4.21,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":3334},"source":{"system":"sec-edgar","filing":"0001415889-25-011243","document":"form4-04232025_080401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588925011243/form4-04232025_080401.xml","form_type":"4"}},{"id":1167133,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-04-24T00:00:05.000Z","date":"2025-04-21","kind":"sale","planned":true,"acquired":false,"shares":3334,"price":30,"value":100020.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024."}],"balance_after":82139,"source":{"system":"sec-edgar","filing":"0001415889-25-011243","document":"form4-04232025_080401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588925011243/form4-04232025_080401.xml","form_type":"4"}},{"id":1167132,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-04-24T00:00:05.000Z","date":"2025-04-21","kind":"exercise","planned":true,"acquired":true,"shares":3334,"price":4.21,"value":14036.14,"ownership":{"direct":true},"balance_after":85473,"source":{"system":"sec-edgar","filing":"0001415889-25-011243","document":"form4-04232025_080401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588925011243/form4-04232025_080401.xml","form_type":"4"}},{"id":1222964,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-06T01:00:13.000Z","date":"2025-03-03","kind":"exercise","planned":true,"acquired":false,"shares":3334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately exercisable."}],"balance_after":93999,"derivative":{"exercise_price":4.21,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":3334},"source":{"system":"sec-edgar","filing":"0001415889-25-007104","document":"form4-03052025_080309.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588925007104/form4-03052025_080309.xml","form_type":"4"}},{"id":1222963,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-03-06T01:00:13.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":901,"price":32.8509,"value":29598.6609,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $32.8509 and the range of prices were between $32.53 and $33.15. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":82139,"source":{"system":"sec-edgar","filing":"0001415889-25-007104","document":"form4-03052025_080309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588925007104/form4-03052025_080309.xml","form_type":"4"}},{"id":1222962,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-03-06T01:00:13.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":2433,"price":31.8848,"value":77575.7184,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $31.8848 and the range of prices were between $31.50 and $32.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":83040,"source":{"system":"sec-edgar","filing":"0001415889-25-007104","document":"form4-03052025_080309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588925007104/form4-03052025_080309.xml","form_type":"4"}},{"id":1222961,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-03-06T01:00:13.000Z","date":"2025-03-03","kind":"exercise","planned":true,"acquired":true,"shares":3334,"price":4.21,"value":14036.14,"ownership":{"direct":true},"balance_after":85473,"source":{"system":"sec-edgar","filing":"0001415889-25-007104","document":"form4-03052025_080309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588925007104/form4-03052025_080309.xml","form_type":"4"}},{"id":1282137,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-06T01:00:05.000Z","date":"2025-02-03","kind":"exercise","planned":true,"acquired":false,"shares":3334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately exercisable."}],"balance_after":97333,"derivative":{"exercise_price":4.21,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":3334},"source":{"system":"sec-edgar","filing":"0001415889-25-003165","document":"form4-02052025_080201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588925003165/form4-02052025_080201.xml","form_type":"4"}},{"id":1282136,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-02-06T01:00:05.000Z","date":"2025-02-03","kind":"sale","planned":true,"acquired":false,"shares":100,"price":43.6,"value":4360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024."}],"balance_after":82139,"source":{"system":"sec-edgar","filing":"0001415889-25-003165","document":"form4-02052025_080201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588925003165/form4-02052025_080201.xml","form_type":"4"}},{"id":1282135,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-02-06T01:00:05.000Z","date":"2025-02-03","kind":"sale","planned":true,"acquired":false,"shares":816,"price":42.7703,"value":34900.5648,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $42.7703 and the range of prices were between $42.56 and $43.00. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":82239,"source":{"system":"sec-edgar","filing":"0001415889-25-003165","document":"form4-02052025_080201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588925003165/form4-02052025_080201.xml","form_type":"4"}},{"id":1282134,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-02-06T01:00:05.000Z","date":"2025-02-03","kind":"sale","planned":true,"acquired":false,"shares":2418,"price":42.0756,"value":101738.8008,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $42.0756 and the range of prices were between $41.55 and $42.40. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":83055,"source":{"system":"sec-edgar","filing":"0001415889-25-003165","document":"form4-02052025_080201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588925003165/form4-02052025_080201.xml","form_type":"4"}},{"id":1282133,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-02-06T01:00:05.000Z","date":"2025-02-03","kind":"exercise","planned":true,"acquired":true,"shares":3334,"price":4.21,"value":14036.14,"ownership":{"direct":true},"balance_after":85473,"source":{"system":"sec-edgar","filing":"0001415889-25-003165","document":"form4-02052025_080201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588925003165/form4-02052025_080201.xml","form_type":"4"}},{"id":1315216,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-01-03T22:10:04.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":63000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"25% of the shares subject to the option vest on January 1, 2026 and the balance will vest in equal monthly installments thereafter over a three year period."}],"balance_after":63000,"derivative":{"exercise_price":53.24,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":63000},"source":{"system":"sec-edgar","filing":"0001415889-25-000554","document":"form4-01032025_050101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588925000554/form4-01032025_050101.xml","form_type":"4"}},{"id":1315215,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-01-03T22:10:04.000Z","date":"2025-01-02","kind":"sale","planned":false,"acquired":false,"shares":200,"price":57.365,"value":11473.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The weighted average sale price for the transaction reported was $57.365 and the range of prices were between $57.35 and $57.38. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":82139,"source":{"system":"sec-edgar","filing":"0001415889-25-000554","document":"form4-01032025_050101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588925000554/form4-01032025_050101.xml","form_type":"4"}},{"id":1315214,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-01-03T22:10:04.000Z","date":"2025-01-02","kind":"sale","planned":false,"acquired":false,"shares":1000,"price":56.7778,"value":56777.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The weighted average sale price for the transaction reported was $56.7778 and the range of prices were between $56.33 and $57.32. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":82339,"source":{"system":"sec-edgar","filing":"0001415889-25-000554","document":"form4-01032025_050101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588925000554/form4-01032025_050101.xml","form_type":"4"}},{"id":1315213,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-01-03T22:10:04.000Z","date":"2025-01-02","kind":"sale","planned":false,"acquired":false,"shares":3444,"price":55.7587,"value":192032.9628,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The weighted average sale price for the transaction reported was $55.7587 and the range of prices were between $55.24 and $56.23. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":83339,"source":{"system":"sec-edgar","filing":"0001415889-25-000554","document":"form4-01032025_050101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588925000554/form4-01032025_050101.xml","form_type":"4"}},{"id":1315212,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-01-03T22:10:04.000Z","date":"2025-01-02","kind":"sale","planned":false,"acquired":false,"shares":5768,"price":54.5111,"value":314420.0248,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The weighted average sale price for the transaction reported was $54.5111 and the range of prices were between $54.21 and $55.14. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":86783,"source":{"system":"sec-edgar","filing":"0001415889-25-000554","document":"form4-01032025_050101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588925000554/form4-01032025_050101.xml","form_type":"4"}},{"id":1315211,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-01-03T22:10:04.000Z","date":"2025-01-02","kind":"sale","planned":false,"acquired":false,"shares":2922,"price":53.7582,"value":157081.4604,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The weighted average sale price for the transaction reported was $53.7582 and the range of prices were between $53.20 and $54.18. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":92551,"source":{"system":"sec-edgar","filing":"0001415889-25-000554","document":"form4-01032025_050101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588925000554/form4-01032025_050101.xml","form_type":"4"}},{"id":1315210,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-01-03T22:10:04.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of restricted stock units (\"RSUs\"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2026."}],"balance_after":95473,"source":{"system":"sec-edgar","filing":"0001415889-25-000554","document":"form4-01032025_050101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588925000554/form4-01032025_050101.xml","form_type":"4"}},{"id":1324271,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-20T23:25:16.000Z","date":"2024-12-19","kind":"exercise","planned":false,"acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vested on January 1, 2024 and the balance vests in equal monthly installments thereafter over a three year period."}],"balance_after":89999,"derivative":{"exercise_price":14.02,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0001415889-24-029989","document":"form4-12202024_111213.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588924029989/form4-12202024_111213.xml","form_type":"4"}},{"id":1324270,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-20T23:25:16.000Z","date":"2024-12-19","kind":"exercise","planned":false,"acquired":false,"shares":9880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vested on January 1, 2023 and the balance vests in equal monthly installments thereafter over a three year period."}],"balance_after":96870,"derivative":{"exercise_price":20.24,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":9880},"source":{"system":"sec-edgar","filing":"0001415889-24-029989","document":"form4-12202024_111213.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588924029989/form4-12202024_111213.xml","form_type":"4"}},{"id":1324269,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-12-20T23:25:16.000Z","date":"2024-12-19","kind":"exercise","planned":false,"acquired":true,"shares":1,"price":14.02,"value":14.02,"ownership":{"direct":true},"balance_after":77473,"source":{"system":"sec-edgar","filing":"0001415889-24-029989","document":"form4-12202024_111213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588924029989/form4-12202024_111213.xml","form_type":"4"}},{"id":1324268,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-12-20T23:25:16.000Z","date":"2024-12-19","kind":"exercise","planned":false,"acquired":true,"shares":9880,"price":20.24,"value":199971.2,"ownership":{"direct":true},"balance_after":77472,"source":{"system":"sec-edgar","filing":"0001415889-24-029989","document":"form4-12202024_111213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588924029989/form4-12202024_111213.xml","form_type":"4"}},{"id":1398532,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-09-27T23:32:58.000Z","date":"2024-09-27","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Immediately exercisable."}],"balance_after":100667,"derivative":{"exercise_price":4.21,"expiration_date":"2031-03-09","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-24-024078","document":"form4-09272024_110955.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588924024078/form4-09272024_110955.xml","form_type":"4"}},{"id":1398531,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-09-27T23:32:58.000Z","date":"2024-09-27","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":45.9551,"value":2297755.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $45.9551 and the range of prices were between $45.55 and $46.50. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":67592,"source":{"system":"sec-edgar","filing":"0001415889-24-024078","document":"form4-09272024_110955.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588924024078/form4-09272024_110955.xml","form_type":"4"}},{"id":1398530,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2024-09-27T23:32:58.000Z","date":"2024-09-27","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":4.21,"value":210500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,189 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan (the \"Plan\") on November 15, 2021, 1,752 shares acquired under the Plan on May 13, 2022, 2,401 shares acquired under the Plan on May 15, 2023 and 2,834 shares acquired under the Plan on May 15, 2024."}],"balance_after":117592,"source":{"system":"sec-edgar","filing":"0001415889-24-024078","document":"form4-09272024_110955.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000141588924024078/form4-09272024_110955.xml","form_type":"4"}},{"id":1693156,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-03T21:50:56.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on January 1, 2025 and the balance will vest in equal monthly installments thereafter over a three year period."}],"balance_after":105000,"derivative":{"exercise_price":11.02,"expiration_date":"2034-01-01","underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001209191-24-000433","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000120919124000433/doc4.xml","form_type":"4"}},{"id":2063073,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-05T21:33:17.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on January 1, 2024 and the balance will vest in equal monthly installments thereafter over a three year period."}],"balance_after":90000,"derivative":{"exercise_price":14.02,"expiration_date":"2033-01-02","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-23-001878","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000120919123001878/doc4.xml","form_type":"4"}},{"id":2444490,"issuer":{"id":4864,"kind":"organization","name":"Janux Therapeutics, Inc."},"owners":[{"id":70603,"kind":"person","name":"Meyer Andrew Hollman","position":1,"cik":"0001864159","reported_name":"Meyer Andrew Hollman","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-05T22:26:14.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":106750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on January 1, 2023 and the balance will vest in equal monthly installments thereafter over a three year period."}],"balance_after":106750,"derivative":{"exercise_price":20.24,"expiration_date":"2032-01-02","underlying":"Common Stock","underlying_shares":106750},"source":{"system":"sec-edgar","filing":"0001209191-22-001827","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864159/000120919122001827/doc4.xml","form_type":"4"}}]}